跳转至内容
Merck
  • Urinary extracellular vesicles as reservoirs of altered proteins during the pathogenesis of polycystic kidney disease.

Urinary extracellular vesicles as reservoirs of altered proteins during the pathogenesis of polycystic kidney disease.

Proteomics. Clinical applications (2015-03-11)
Gabriella Pocsfalvi, Delfin A A Raj, Immacolata Fiume, Annalisa Vilasi, Francesco Trepiccione, Giovambattista Capasso
摘要

Recent findings indicate that urinary extracellular vesicles (EVs) might reflect the pathophysiological state of urinary system; and that EVs-induced ciliary signaling is a possible mechanism of intercellular communication within the tract. Here, we aimed to analyze the protein expression of urinary EVs during autosomal dominant polycystic kidney disease (ADPKD). EVs were isolated from pooled urine samples of healthy control and ADPKD patients at two different stages of the disease and under tolvaptan treatment using the double-cushion ultracentrifugation method. Proteins were identified and quantified by iTRAQ and multidimensional protein identification technology (MudPIT)-based quantitative proteomics. Quantitative analyses identified 83 differentially expressed EV proteins. Many of these have apical membrane origin and are involved in signal transduction pathways of primary cilia, Ca(2+) -activated signaling, cell-cycle regulation, and cell differentiation. The reduced AQP-2 and the increased APO-A1 levels observed in all ADPKD-affected groups may reflects the impaired renal concentrating capability of these patients and correlated with estimated glomerular filtration rate decline. The levels of some upregulated proteins involved in Ca(2+) -activated signaling declined upon tolvaptan treatment. The results obtained suggest that the quantitative proteomics of urinary EVs might be useful to monitor proteins difficult to access noninvasively, and thus advance our understanding of urinary tract physiology and pathology.

材料
货号
品牌
产品描述

Sigma-Aldrich
3-吗啉丙磺酸, ≥99.5% (titration)
Sigma-Aldrich
苯甲磺酰氟, ≥98.5% (GC)
Sigma-Aldrich
2-二(2-羟乙基)氨基-2-羟甲基-1,3-丙二醇, ≥98.0% (titration)
Sigma-Aldrich
3-吗啉丙磺酸, BioPerformance Certified, suitable for cell culture, ≥99.5% (titration)
Sigma-Aldrich
叠氮化钠, ReagentPlus®, ≥99.5%
Sigma-Aldrich
叠氮化钠, BioUltra, ≥99.5% (T)
SAFC
2-二(2-羟乙基)氨基-2-羟甲基-1,3-丙二醇
Sigma-Aldrich
3-吗啉丙磺酸, BioXtra, ≥99.5% (titration)
Sigma-Aldrich
叠氮化钠, purum p.a., ≥99.0% (T)
Sigma-Aldrich
苯甲磺酰氟, ≥99.0% (T)
Sigma-Aldrich
2-二(2-羟乙基)氨基-2-羟甲基-1,3-丙二醇, BioUltra, ≥99.0% (NT)
Sigma-Aldrich
2-二(2-羟乙基)氨基-2-羟甲基-1,3-丙二醇, BioPerformance Certified, suitable for cell culture, suitable for insect cell culture, ≥98.0%
Sigma-Aldrich
甲酸, ≥95%, FCC, FG
Sigma-Aldrich
2-二(2-羟乙基)氨基-2-羟甲基-1,3-丙二醇, BioXtra, ≥98.0% (titration)
Sigma-Aldrich
叠氮化钠, BioXtra
SAFC
3-吗啉丙磺酸
SAFC
2-二(2-羟乙基)氨基-2-羟甲基-1,3-丙二醇
Sigma-Aldrich
3-吗啉丙磺酸, anhydrous, free-flowing, Redi-Dri, ≥99.5%
Sigma-Aldrich
二喹啉甲酸 二钠盐 水合物, ≥98% (HPLC)